MedPageToday
MedPage Today) — A dose-reduction strategy for a commonly used first-line combination in pancreatic cancer resulted in similar survival outcomes but improved tolerability, a randomized phase II study showed.
In patients with stable disease following…
Read More
Dose-Reduced Chemo Regimen Promising in Metastatic Pancreatic Cancer
Michele Redner
07:53
MedPage Today) — A dose-reduction strategy for a commonly used first-line combination in pancreatic cancer resulted in similar survival outcomes but improved tolerability, a randomized phase II study showed. In patients with stable disease following…
